The global minimal residual disease testing market size was valued at USD 2.5 billion in 2024 and is projected to grow from USD 3.0 billion in 2026 to USD 4.5 billion by 2030, at a CAGR of 10.1% from 2025 to 2030. North America dominated the market, accounting for a revenue share of 46.2... Read More »
June 2025The global STI and vaginitis PCR testing market size was estimated at USD 661.0 million in 2024 and is projected to reach USD 1,111.9 million by 2030, growing at a CAGR of 9.2% from 2025 to 2030. This is attributed to the rising global incidence of sexually transmitted and vaginal infect... Read More »
June 2025The global oncology companion diagnostic market size was valued at USD 5.1 billion in 2024 and is projected to grow from USD 5.9 billion in 2026 to USD 8.4 billion by 2030, at a CAGR of 9.0% from 2025 to 2030. North America dominated the market, accounting for a revenue share of 40.2% in... Read More »
June 2025The global predictive biomarkers market size was estimated at USD 24.30 billion in 2024 and is projected to grow at a CAGR of 18.02% from 2025 to 2030. The market is experiencing significant growth driven by several factors such as advancements in genomics and precision medicines, increa... Read More »
May 2025The Canada in vitro diagnostics market size was valued at USD 8.05 billion in 2024 and is projected to witness a CAGR of 4.8% from 2025 to 2030. The increasing prevalence of chronic diseases such as cancer, inflammatory conditions, autoimmune disorders, and infectious diseases is one of ... Read More »
May 2025The global dengue testing market size was estimated at USD 612.53 million in 2024 and is projected to reach USD 822.61 million by 2030, growing at a CAGR of 5.22% from 2025 to 2030, driven by escalating dengue outbreaks, technological advancements, and increased public health initiatives... Read More »
May 2025The global infectious disease in vitro diagnostics market size was estimated at USD 24.30 billion in 2024 and is projected to reach USD 28.05 billion by 2030, growing at a CAGR of 2.5% from 2025 to 2030. The growing geriatric population susceptible to infectious diseases, rising awareness about early testing, h... Read More »
May 2025The global ATP assays market size was valued at USD 3.6 billion in 2024 and is projected to grow from USD 4.1 billion in 2026 to USD 5.6 billion by 2030, at a CAGR of 7.9% from 2025 to 2030. North America dominated the market, accounting for a revenue share of 39.3% in 2024. This is attr... Read More »
May 2025The global central lab market size was valued at USD 3.5 billion in 2024 and is projected to grow from USD 3.9 billion in 2026 to USD 5.0 billion by 2030, at a CAGR of 6.6% from 2025 to 2030. North America dominated the market, accounting for a revenue share of 40.8% in 2024.... Read More »
May 2025The global personalized cancer vaccine market size was valued at USD 208.3 million in 2024 and is projected to grow from USD 246.5 million in 2026 to USD 1,446.6 million by 2030, at a CAGR of 44.9% from 2025 to 2030. North America dominated the market, accounting for a revenue share of 3... Read More »
May 2025The global preimplantation genetic testing market size was valued at USD 852.4 million in 2024 and is projected to grow from USD 971.6 million in 2026 to USD 1,282.1 million by 2030, at a CAGR of 7.1% from 2025 to 2030. Europe dominated the market, accounting for a revenue share of 34.6%... Read More »
May 2025The global CRISPR-Based diagnostics market size was valued at USD 3.1 billion in 2024 and is projected to grow from USD 4.0 billion in 2026 to USD 7.6 billion by 2030, at a CAGR of 16.6% from 2025 to 2030. North America dominated the market, accounting for a revenue share of 36.8% in 202... Read More »
May 2025The global STD diagnostics Market size was estimated at USD 10.6 billion in 2024 and is projected to reach USD 16.1 billion by 2030, growing at a CAGR of 7.1% from 2025 to 2030.The market is primarily influenced by advancements in diagnostic technology and increased government ... Read More »
May 2025The global epigenetics diagnostics market size was valued at USD 16.69 billion in 2024 and is projected to grow at a CAGR of 15.5% from 2025 to 2030. The high growth is mainly attributed to the increase in investment, funds, and approvals for epigenetics research & development, growi... Read More »
May 2025The global bacterial and viral specimen collection market size was valued at USD 15.49 billion in 2024 and is expected to grow at a CAGR of 14.5% from 2025 to 2030, driven bythe increasing prevalence of infectious diseases and rising awareness and adoption of preventive healthcare.... Read More »
May 2025The global non-alcoholic steatohepatitis biomarkers market size was valued at USD 1.59 billion in 2024 and is expected to grow at a CAGR of 23.3% from 2025 to 2030. The increasing prevalence of chronic liver diseases, particularly Non-alcoholic Steatohepatitis (NASH), is significantly ex... Read More »
April 2025The global comprehensive metabolic panel testing market size was valued at USD 12.6 billion in 2024 and is projected to grow from USD 15.3 billion in 2026 to USD 22.1 billion by 2030, at a CAGR of 9.5% from 2025 to 2030. North America dominated the market, accounting for a revenue share ... Read More »
April 2025The global blood filtration and purification market size was valued at USD 3.7 billion in 2024 and is projected to grow from USD 4.3 billion in 2026 to USD 5.6 billion by 2030, at a CAGR of 7.3% from 2025 to 2030. North America dominated the market, accounting for a revenue share of 46.1% in 2024. The rising prevale... Read More »
April 2025The global next generation tissue biomarkers market size was valued at USD 3.0 billion in 2024 and is projected to grow from USD 3.6 billion in 2026 to USD 6.0 billion by 2030, at a CAGR of 12.7% from 2025 to 2030. North America dominated the market, accounting for a revenue share of 46.... Read More »
April 2025The global blood typing market size was valued at USD 2.1 billion in 2024 and is projected to grow from USD 2.5 billion in 2026 to USD 3.5 billion by 2030, at a CAGR of 8.6% from 2025 to 2030. North America dominated the market, accounting for a revenue share of 42.8% in 2024. The market... Read More »
April 2025